Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,076–2,100 of 7,816 matching trials · page 84 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
TEsting METformin Against Cognitive Decline in HD NCT04826692 Metformin; Placebo Runs in: Spain · 9 sites |
PHASE3 other |
COMPLETED | 60 | Instituto de Investigacion Sanitaria La Fe OTHER |
2025-09-25 |
|
Development of an EEG Diagnostic for Alzheimer's Disease NCT04954183 Runs in: United States · 1 site |
NA other |
COMPLETED | 29 | Mayo Clinic OTHER |
2025-09-25 |
|
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction NCT05126238 Lithium Carbonate; Placebo Runs in: Russia · 1 site |
PHASE3 other |
TERMINATED | 107 | Negovsky Reanimatology Research Institute OTHER_GOV |
2025-09-25 |
|
Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1 NCT05813652 Pre-pandemic time period (Jun 22, 2018 to March 12, 2020); Peri-pan... Runs in: Canada · 1 site |
NA other |
COMPLETED | 919,928 | McMaster University OTHER |
2025-09-25 |
|
Caring for Caregivers and People Living With Dementia Under Home-Based Primary Care NCT05849259 Dementia Care Quality at Home Runs in: United States · 2 sites |
NA other |
COMPLETED | 50 | Massachusetts General Hospital OTHER |
2025-09-25 |
|
Cognitive Stimulation Therapy for Residents With Dementia in Nursing Homes NCT06978972 Cognitive Stimulation Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 10 | Northern Kentucky University OTHER |
2025-09-25 |
|
TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease NCT05615233 TACAD; Alzheimer's Association website Runs in: United States · 1 site |
NA other |
COMPLETED | 54 | University of Texas at Austin OTHER |
2025-09-24 |
|
A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns NCT07189754 Sabroxy™ (Oroxylum indicum extract); Placebo Runs in: United States · 1 site |
NA other |
COMPLETED | 70 | SF Research Institute, Inc. NETWORK |
2025-09-24 |
|
Caregiving While Black: LIVE NCT06605391 Caregiving While Black-LIVE Runs in: United States · 1 site |
NA other |
COMPLETED | 40 | Emory University OTHER |
2025-09-23 |
|
Effects of Personalized Music Listening in Advanced Alzheimer's NCT06765434 Music ( Dmitri Shostakovich's Jazz Waltz Suite); Music( Personalized music) Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 54 | Okan University OTHER |
2025-09-23 |
|
The Effects of a Meditation Intervention on the Psychological Burden of Long-Term Care Professionals and Family Caregivers NCT07188454 Mindfulness-Based Digital Intervention (AIZEN Program) Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 60 | National Health Research Institutes, Taiwan OTHER |
2025-09-23 |
|
Evaluation of the PACE/PACENET BHL Caregiver Program NCT02463708 BHL COTP Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 350 | University of Pennsylvania OTHER |
2025-09-22 |
|
The Sleep Amyloid, Slow WAve Race and Ethnicity Study NCT03814603 PET-MR Scan; PiB Runs in: United States · 1 site |
NA other |
COMPLETED | 210 | NYU Langone Health OTHER |
2025-09-22 |
|
Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement. NCT04754906 Sequence 1; Sequence 2; Sequence 3 Runs in: France · 1 site |
NA other |
RECRUITING | 684 | Centre Hospitalier Universitaire Dijon OTHER |
2025-09-22 |
|
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease NCT05026177 Simufilam; Placebo Runs in: Canada; Puerto Rico; South Korea; United States · 89 sites |
PHASE3 other |
TERMINATED | 1,125 | Cassava Sciences, Inc. INDUSTRY |
2025-09-22 |
|
Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer. NCT05425550 medidux™ app Runs in: Switzerland · 1 site |
NA other |
TERMINATED | 196 | Palleos Healthcare GmbH INDUSTRY |
2025-09-22 |
|
Prevention of ANxiety and Depression Over Risk Assessment NCT07185867 Pandora-1 app with high levels of personalization, interaction, mon... Runs in: Spain · 1 site |
NA other |
NOT_YET_RECRUITING | 2,595 | The Mediterranean Institute for the Advance of Biotechnology and Health Research OTHER |
2025-09-22 |
|
Nasal Protollin in Early Symptomatic Alzheimer's Disease NCT07187141 Protollin Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 16 | Brigham and Women's Hospital OTHER |
2025-09-22 |
|
Post-stroke Cognitive Impairment and Dementia NCT01339195 French adaptation of NINDS-Canadian Stroke Network battery Runs in: France · 7 sites |
NA other |
COMPLETED | 1,635 | Centre Hospitalier Universitaire, Amiens OTHER |
2025-09-19 |
|
Predictive Value of Flow MRI in Normal Pressure Hydrocephalus Surgery NCT01815775 clinical and imaging examinations Runs in: France · 1 site |
EARLY_PHASE1 other |
COMPLETED | 30 | Centre Hospitalier Universitaire, Amiens OTHER |
2025-09-19 |
|
Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease NCT03252535 Cellavita HD lower dose; Cellavita HD higher dose; Placebo Runs in: Brazil · 1 site |
PHASE2 other |
COMPLETED | 49 | Azidus Brasil INDUSTRY |
2025-09-19 |
|
Design of a Prototype Garment Adapted to Demented Elderly Subjects With Disturbing Behavioral Problems in the Management of Sphincter Disorders NCT05649839 garment Runs in: France · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 40 | Centre Hospitalier Universitaire, Amiens OTHER |
2025-09-19 |
|
Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone NCT05746390 Home Alone Runs in: United States · 1 site |
NA other |
COMPLETED | 65 | University of Minnesota OTHER |
2025-09-19 |
|
nuTritiOn and deMentia AT hOme (TOMATO) NCT05866094 Nutritional Intervention Runs in: United Kingdom · 5 sites |
NA other |
COMPLETED | 139 | Bournemouth University OTHER |
2025-09-19 |
|
IONA Longitudinal Cohort Study NCT05892952 Runs in: United Kingdom · 1 site |
NA other |
RECRUITING | 10,000 | Brain Health Scotland Life Sciences Ltd INDUSTRY |
2025-09-19 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial